Pharmacokinetic/Pharmacodynamic Target Attainment of Tigecycline in Patients with Hepatic Impairment in a Real-World Setting

BACKGROUND: This study aimed to investigate the pharmacokinetic/pharmacodynamic (PK/PD) target attainment of various tigecycline dosing regimens in real-world patients with impaired liver function. METHODS: The clinical data and serum concentrations of tigecycline were extracted from the patients�...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaoxuan, Jin, Lu, Luo, Xuemei, An, Shurun, Wang, Min, Zhu, Huaijun, Zhou, Yujie, Liu, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Drug Monitoring 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635337/
https://www.ncbi.nlm.nih.gov/pubmed/37296502
http://dx.doi.org/10.1097/FTD.0000000000001115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635337/
https://www.ncbi.nlm.nih.gov/pubmed/37296502
http://dx.doi.org/10.1097/FTD.0000000000001115

Ejemplares similares